InvestorsHub Logo
Followers 253
Posts 18023
Boards Moderated 0
Alias Born 01/19/2006

Re: lorbas95 post# 313381

Saturday, 12/05/2020 8:20:31 PM

Saturday, December 05, 2020 8:20:31 PM

Post# of 427497
#313381–Dr. Bhatt says, in his review of 2020 AHA Scientific Sessions, that having a composition capable of lowering trigs is not enough to establish that composition will reduce CVD risk as well. Now apply the video and transcript text to where H finds itself today. The composition in H’s capsule is not the same(identical) as the composition in Vascepa capsule; H has run no Reduce-It outcomes study on its composition within its capsule.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News